Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acrivastine (Acrivastin) is a short-acting histamine 1 receptor antagonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 31.00 | |
10 mg | In stock | $ 47.00 | |
25 mg | In stock | $ 100.00 | |
50 mg | In stock | $ 163.00 | |
100 mg | In stock | $ 233.00 | |
500 mg | In stock | $ 583.00 | |
1 g | In stock | $ 833.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 34.00 |
Description | Acrivastine (Acrivastin) is a short-acting histamine 1 receptor antagonist. |
In vivo | Acrivastine, administered typically at 8mg thrice daily, is a highly effective and well-tolerated antihistamine for managing chronic urticaria and allergic rhinitis, offering minimal drowsiness compared to clemastine and similar adverse effect profiles to placebo or terfenadine. It demonstrates superior efficacy over placebo and comparability to clemastine, hydroxyzine, chlorpheniramine, cyproheptadine, and terfenadine in treating histamine-related dermatoses. Both 4mg and 8mg doses notably improve symptoms of seasonal allergic rhinitis, including sneezing, runny nose, and overall discomfort, with the 8mg dose additionally reducing watery eyes and itchy throat symptoms. Therefore, acrivastine is recognized as both effective and well-tolerated in treating seasonal allergic rhinitis. |
Synonyms | Acrivastin, BW825C, Semprex |
Molecular Weight | 348.44 |
Formula | C22H24N2O2 |
CAS No. | 87848-99-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (14.35 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Acrivastine 87848-99-5 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor Acrivastin inhibit BW825C Semprex Inhibitor inhibitor